Entrada Therapeutics Announces Pricing of Upsized Initial Public Offering
28 oct. 2021 22h21 HE
|
Entrada Therapeutics, Inc.
BOSTON, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company aiming to transform the lives of patients by establishing Endosomal Escape Vehicle (EEV™)...